Painless Jaundice and a Pancreatic Head Mass: Resectability and Drainage Decisions
A 63-year-old man presents with 3 weeks of painless jaundice, generalized pruritus, and 6 kg of unintentional weight loss. He has no fever, chills, or abdominal pain. Total bilirubin is 12.4 mg/dL with a direct fraction of 9.8 mg/dL; CA 19-9 is 480 U/mL and CEA is normal. Contrast-enhanced CT shows a 3.1 cm hypodense mass in the pancreatic head. The superior mesenteric vein and portal vein are abutted but not invaded over less than 180 degrees of their circumference; the superior mesenteric artery and celiac axis are clear. There are no liver lesions, ascites, or peritoneal nodules. Endoscopic ultrasound-guided FNA confirms pancreatic ductal adenocarcinoma. He is ECOG performance status 1, has no cholangitis, and has a body mass index of 21 kg/m². The multidisciplinary team is debating preoperative biliary drainage, staging laparoscopy, and timing of surgery.
1. Should this patient undergo routine preoperative biliary drainage before pancreatectomy? Explain your answer using his bilirubin, symptoms, and expected timing of surgery.
Read the worked answer
Routine preoperative biliary drainage is not indicated. Multiple trials and guidelines show that routine stenting before pancreaticoduodenectomy increases stent-related complications, including cholangitis, pancreatitis, bleeding, and stent occlusion, and does not improve surgical outcomes. It also commits the patient to a delay and to a contaminated biliary tree at operation.
Acceptable indications for drainage in this patient:
- Cholangitis, which he does not have.
- Severe, intractable pruritus that cannot be controlled medically.
- Severe malnutrition or renal impairment that needs time to correct.
- A planned delay for neoadjuvant therapy or staging that will last several weeks.
His bilirubin of 12.4 mg/dL and pruritus are concerning but not automatic indications if surgery can proceed within 1 to 2 weeks. The better plan is to assess the severity of pruritus, start symptomatic treatment, optimize nutrition, and schedule resection promptly. If surgery is delayed beyond 2 weeks or pruritus is disabling, a short plastic stent or percutaneous drainage can be considered, accepting the infectious risk.
If the team elects neoadjuvant chemotherapy, drainage is not mandatory either; it is used selectively for pruritus, cholangitis, or a bilirubin level that would delay chemotherapy.
2. How do you determine resectability, and is staging laparoscopy justified in this patient?
Read the worked answer
Resectability is determined by vascular contact and the presence of distant disease. This CT shows tumor abutment of the superior mesenteric vein and portal vein over less than 180 degrees, without arterial encasement or occlusion. That is generally resectable, with a planned venous resection only if reconstruction is feasible. Clear superior mesenteric artery and celiac axis, absent liver lesions, absent ascites, and absent peritoneal nodules support resection.
Staging laparoscopy: It is most useful when the risk of occult peritoneal or small liver metastases is high. Risk factors include a large or poorly differentiated tumor, markedly elevated CA 19-9, weight loss, and indeterminate findings on imaging. His CA 19-9 of 480 U/mL and 6 kg weight loss make laparoscopy reasonable before committing to aWhipple procedure, especially because a positive finding would spare him a major operation. It is not mandatory for every resectable cancer, but it is justified here.
If laparoscopy is negative, proceed with resection or enroll in a neoadjuvant protocol according to multidisciplinary team preference. If positive, treat as metastatic disease and avoid pancreatectomy.
3. Five days later he returns with fever of 38.9°C, right upper quadrant pain, confusion, and blood pressure of 90/60 mmHg. Bilirubin is now 15 mg/dL. What is the immediate management, and how does it alter the surgical plan?
Read the worked answer
This is acute cholangitis with sepsis and organ dysfunction. The immediate priority is resuscitation and biliary decompression, not pancreatic resection.
Immediate steps:
- Obtain blood cultures and start broad-spectrum antibiotics covering gram-negative enteric organisms and anaerobes, for example piperacillin-tazobactam, adjusted to local resistance patterns.
- Resuscitate with balanced crystalloid, monitor urine output and lactate, and support blood pressure.
- Perform biliary drainage urgently, ideally within 24 hours. Endoscopic retrograde cholangiopancreatography with stent placement is preferred; percutaneous transhepatic drainage is used if ERCP fails or is not feasible.
- Admit to a monitored bed or intensive care if hypotension persists.
Effect on the cancer plan: Defer pancreatectomy until sepsis resolves, nutrition is optimized, and the patient is physiologically recovered, usually several weeks later. Reassess staging because cholangitis and stent placement can complicate imaging interpretation. The prior debate about routine drainage is now moot: drainage is indicated because cholangitis has occurred. Document that the stent is a bridge, not a definitive treatment.